丽珠医药(01513)：截至8月末回购共计1338.3万股A股股份

Core Viewpoint - Lijun Pharmaceutical (01513) announced a share buyback program, indicating confidence in its stock value and commitment to returning capital to shareholders [1] Summary by Categories Share Buyback Details - The company repurchased a total of 13.383 million A-shares, representing 1.48% of its total share capital [1] - The highest purchase price was RMB 41.99 per share, while the lowest was RMB 33.21 per share [1] - The total funds used for the buyback amounted to RMB 491 million, excluding transaction costs [1]